Significant Ownership of Venrock Healthcare Capital Partners III, L.P.

Signature - Title
/s/ Sherman G. Souther - By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Venrock Healthcare Capital Partners III, L.P..

Notify me when Venrock Healthcare Capital Partners III, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Venrock Healthcare Capital Partners III, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SVRA Savara Inc. Common Stock, par value $0.001 per share 9.9% $123,617,225 +$48,545,450 20,881,288 +65% Venrock Healthcare Capital Partners III, L.P. 31 Dec 2025
ORKA ORUKA THERAPEUTICS, INC. Common Stock, par value $0.001 per share 9.9% $94,411,973 +$14,637,703 4,909,619 +18% Venrock Healthcare Capital Partners III, L.P. 30 Sep 2025
JBIO JADE BIOSCIENCES, INC. Common Stock, $0.0001 par value 9.9% $70,905,847 +$26,271,533 5,115,862 +59% Venrock Healthcare Capital Partners III, L.P. 31 Dec 2025
CYBN Cybin Inc. Common Shares, no par value 9.9% $30,106,217 5,111,412 Venrock Healthcare Capital Partners III, L.P. 31 Oct 2025
VOR VOR BIOPHARMA INC. Common Stock, $0.0001 par value per share 9.9% $30,049,977 +$19,734,899 2,216,075 +191% Venrock Healthcare Capital Partners III, L.P. 31 Dec 2025
KRRO Korro Bio, Inc. Common Stock, par value $0.001 per share 9.9% $17,760,012 1,488,685 Venrock Healthcare Capital Partners III, L.P. 10 Mar 2026
TENX Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share 9.9% $10,429,033 +$2,106,834 692,959 +25% Venrock Healthcare Capital Partners III, L.P. 31 Dec 2025
SRZN Surrozen, Inc. Common Stock, $0.0001 par value per share 9.9% $8,742,911 872,546 Venrock Healthcare Capital Partners III, L.P. 26 Mar 2025
ZURA ZURA BIO LIMITED Class A Ordinary Shares, par value $0.0001 per share 9.9% $8,322,892 -$888,073 6,353,353 -9.6% Venrock Healthcare Capital Partners III, L.P. 30 Jun 2025
GLYC Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share 9.9% 1,391,196 Venrock Healthcare Capital Partners III, L.P. 13 Jun 2025
CBIO Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share 9.5% $29,460,007 2,666,064 Venrock Healthcare Capital Partners III, L.P. 31 Dec 2025
CTMX CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share 9.4% $49,641,185 +$8,195,110 15,561,500 +20% Venrock Healthcare Capital Partners III, L.P. 30 Sep 2025
CASI CASI Pharmaceuticals, Inc. Ordinary shares, par value US$0.0001 9.2% $2,066,749 1,987,259 Venrock Healthcare Capital Partners III, L.P. 31 Dec 2025
ENGN enGene Holdings Inc. Common Shares 7.1% $39,984,449 -$2,304,500 4,771,414 -5.4% Venrock Healthcare Capital Partners III, L.P. 31 Dec 2025
IPSC Century Therapeutics, Inc. Common Stock, par value $0.0001 per share 7.1% $12,354,782 +$8,606,536 13,043,478 +230% Venrock Healthcare Capital Partners III, L.P. 09 Jan 2026
ANL Adlai Nortye Ltd. Ordinary Shares, $0.001 par value per share 6.1% $15,710,255 9,638,193 Venrock Healthcare Capital Partners III, L.P. 04 Feb 2026
GLTO Galecto, Inc. Common Stock, $0.00001 par value per share 6% $78,630,443 3,603,595 Venrock Healthcare Capital Partners III, L.P. 09 Feb 2026
ORIC ORIC Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 5.8% $57,556,972 -$9,335,442 5,676,230 -14% Venrock Healthcare Capital Partners III, L.P. 31 Dec 2025
ELVN ENLIVEN THERAPEUTICS, INC. Common Stock, $0.001 par value per share 5.4% $66,042,996 3,226,331 Venrock Healthcare Capital Partners III, L.P. 30 Sep 2025
PRAX Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share 4.9% $37,813,688 -$6,466,960 1,016,497 -15% Venrock Healthcare Capital Partners III, L.P. 31 Mar 2025
SYRE Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.6% $40,335,429 2,685,448 Venrock Healthcare Capital Partners III, L.P. 31 Dec 2024
VRDN Viridian Therapeutics, Inc. Common Stock, $0.01 par value per share 4.5% $48,373,931 3,575,309 Venrock Healthcare Capital Partners III, L.P. 31 Dec 2024
ATXS Astria Therapeutics, Inc. Common Stock, $0.001 par value per share 4.4% $12,704,489 2,457,348 Venrock Healthcare Capital Partners III, L.P. 31 Dec 2024
APLT Applied Therapeutics, Inc. Common Stock $0.0001 par value per share 4.1% $2,171,407 -$2,432,661 5,567,709 -53% Venrock Healthcare Capital Partners III, L.P. 31 Mar 2025
PHVS Pharvaris N.V. Ordinary shares, par value EURO0.12 per share 3.8% $51,436,214 2,047,620 Venrock Healthcare Capital Partners III, L.P. 30 Jun 2025
OCUL Ocular Therapeutix Inc Common Stock, $0.0001 par value per share 3.2% $81,120,329 -$71,516,295 6,862,972 -47% Venrock Healthcare Capital Partners III, L.P. 31 Dec 2025
CDTX CIDARA THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 3.2% $32,299,508 -$23,243,750 639,088 -42% Venrock Healthcare Capital Partners III, L.P. 30 Jun 2025
DNTH Dianthus Therapeutics, Inc. Common Stock, $0.001 par value per share 3.1% $20,060,000 1,000,000 Venrock Healthcare Capital Partners III, L.P. 30 Jun 2025
AQST Aquestive Therapeutics, Inc. Common stock, $0.001 par value per share 2.9% $7,494,890 2,629,786 Venrock Healthcare Capital Partners III, L.P. 31 Dec 2024
MRSN MERSANA THERAPEUTICS, INC. Common Stock, $0.0001 par value per share 2.9% $1,286,757 -$2,406,047 3,574,325 -65% Venrock Healthcare Capital Partners III, L.P. 31 Mar 2025
FDMT 4D MOLECULAR THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 1.5% $2,202,200 -$7,393,006 677,600 -77% Venrock Healthcare Capital Partners III, L.P. 31 Mar 2025
ABVX Abivax SA Ordinary Shares, nominal value 0.01 euro per share 0.8% $48,964,292 576,729 Venrock Healthcare Capital Partners III, L.P. 30 Sep 2025
PCSC Perceptive Capital Solutions Corp Class A Ordinary Shares, par value $0.0001 per share 0% $0 0 Venrock Healthcare Capital Partners III, L.P. 31 Dec 2025
ADVM ADVERUM BIOTECHNOLOGIES, INC. Common Stock, $0.0001 par value 0% $0 0 Venrock Healthcare Capital Partners III, L.P. 31 Dec 2024

Schedules 13D/G Reported by Venrock Healthcare Capital Partners III, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.